Sandra C Ordonez-Rubiano

Selective and Cell-Active PBRM1 Bromodomain Inhibitors Discovered through NMR Fragment Screening.

Brian C. Smith, Michael D. Olp, B. Volkman, 2022, Journal of medicinal chemistry.

A Potent, Selective CBX2 Chromodomain Ligand and Its Cellular Activity During Prostate Cancer Neuroendocrine Differentiation

Alisha Dhiman, Casey J. Krusemark, Surbhi Sood, 2021, Chembiochem : a European journal of chemical biology.

SWI/SNF chromatin remodelers in prostate cancer progression

Brayden P Strohmier, Emily C. Dykhuizen, Sandra C Ordonez-Rubiano, 2024, Frontiers in Epigenetics and Epigenomics.

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer.

Brian C. Smith, Surbhi Sood, Sijie Wang, 2023, Journal of medicinal chemistry.